Viridian Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.4% | 91.5% | 891.8% | 764.2% | 307.7% | 419.3% | 134.1% | 383.8% | 783.8% | 1,729.8% | 2,352.4% | 342.0% | 1,298.8% | 729.2% | 737.1% | 2,283.3% | – | 28,248.1% | 951.5% | 1,152.8% | 3,904.3% | 10,464.5% | 8,215.7% | 8,481.3% | 1,851.0% | 37,444.8% | 209.2% | 600.0% | 465.3% | 486.1% | 479.2% | 8,043.1% | – | 170.8% | – | – | – | 242.4% | 85.8% | 41.2% | – | |
| 32.6% | 8.5% | -791.8% | -664.2% | -207.7% | -319.3% | -34.1% | -283.8% | -683.8% | -1,629.8% | -2,252.4% | -242.0% | -1,198.8% | -629.2% | 100.0% | 100.0% | – | -28,148.1% | -851.5% | -1,052.8% | -3,804.3% | -10,364.5% | -8,115.7% | -8,381.3% | -1,751.0% | -37,344.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -142.4% | 100.0% | 100.0% | 99.6% | |
| 25.4% | 2.8% | 891.8% | 764.2% | 307.7% | 419.3% | 134.1% | 383.8% | 783.8% | 1,729.8% | 2,352.4% | 342.0% | 1,298.8% | 956.5% | 737.1% | 2,283.3% | – | 28,248.1% | 951.5% | 1,152.8% | 3,904.3% | 10,464.5% | 8,215.7% | 8,481.3% | 1,851.0% | 37,444.8% | 51,775.5% | 55,670.8% | 42,201.4% | 53,551.4% | 56,866.7% | 78,045.8% | 80,416.3% | 99,944.4% | 106,715.3% | 115,501.3% | 122.2% | 67,581.1% | 55,057.4% | 25,203.2% | 456.5% | |
| 169.5% | 324.2% | 710.2% | 359.5% | 153.4% | 213.8% | 62.5% | 122.3% | 285.6% | 566.2% | 902.4% | 113.6% | 417.0% | 288.0% | 328.9% | 1,610.7% | – | 10,253.7% | 424.5% | 598.4% | 2,990.9% | 3,224.8% | 3,869.9% | 3,167.2% | 741.5% | 9,384.8% | 22,276.5% | 26,755.6% | 29,043.1% | 45,823.6% | 20,868.1% | 22,313.9% | 16,753.5% | 21,644.4% | 23,754.2% | 26,954.7% | 34.5% | 25,510.6% | 27,431.9% | 19,357.4% | 213.2% | |
| 236.9% | 357.5% | 1,601.9% | 1,123.7% | 461.1% | 633.1% | 196.6% | 506.1% | 1,069.4% | 2,296.0% | 3,254.8% | 455.7% | 1,715.8% | 515.2% | 1,065.9% | 3,894.0% | – | 139,625.9% | 424.5% | 598.4% | 2,990.9% | 3,224.8% | 3,869.9% | 3,167.2% | 741.5% | 9,384.8% | 74,052.0% | 82,426.4% | 71,244.4% | 99,375.0% | 77,734.7% | 100,359.7% | 97,169.8% | 121,588.9% | 130,469.4% | 142,456.0% | 156.7% | 92,849.2% | 82,489.4% | 44,560.6% | 669.2% | |
| -204.3% | -723.9% | -1,501.9% | -1,023.7% | -361.1% | -533.1% | -96.6% | -406.1% | -969.4% | -2,196.0% | -3,154.8% | -355.7% | -1,615.8% | -1,144.4% | -965.9% | -3,794.0% | – | -167,774.1% | -1,276.0% | -1,651.2% | -6,795.2% | -13,589.3% | -11,985.6% | -11,548.4% | -2,492.5% | -46,729.5% | -73,952.0% | -82,326.4% | -71,144.4% | -99,275.0% | -77,634.7% | -100,259.7% | -97,069.8% | -121,488.9% | -130,369.4% | -142,356.0% | -56.7% | -92,991.7% | -82,389.4% | -44,460.6% | -569.7% | |
| 2.6% | 3.4% | 15.4% | 8.9% | 3.6% | 15.9% | 4.4% | 9.8% | 23.5% | 47.9% | 62.4% | 9.1% | 29.4% | 19.3% | 17.0% | 56.0% | – | 333.3% | 12.4% | 0.0% | 0.0% | 1.4% | 90.7% | 60.2% | 13.7% | 160.0% | 168.4% | 230.6% | 833.3% | 1,272.2% | 815.3% | 829.2% | 1,167.4% | 1,191.7% | 813.9% | 685.3% | 0.8% | 5,006.1% | 2,455.3% | 2,925.0% | 26.6% | |
| -206.9% | -736.8% | -1,510.8% | -1,018.4% | -357.7% | -535.7% | -97.4% | -399.4% | -954.6% | -2,167.4% | -3,126.1% | -353.9% | -1,615.8% | -1,149.8% | -971.5% | -3,830.4% | – | -168,040.7% | -1,272.2% | -1,648.1% | -6,751.4% | -13,526.2% | -11,894.9% | -11,519.9% | -2,418.8% | -43,604.8% | -69,541.8% | -76,476.4% | -66,194.4% | -92,861.1% | -67,419.4% | -90,268.1% | -89,173.3% | -110,729.2% | -120,711.1% | -134,313.3% | -49.0% | -91,178.0% | -74,397.9% | -44,760.2% | -544.1% | |
| – | -9.4% | 6.5% | 14.2% | 6.9% | 6.5% | 3.5% | 16.5% | 38.3% | 60.7% | 91.1% | 8.1% | 19.1% | 5.7% | 3.3% | 19.6% | – | 240.7% | 3.8% | 0.8% | 43.8% | 1.4% | -90.7% | 88.7% | -73.6% | -3,124.8% | -107.1% | 6,080.6% | -187.5% | 7,686.1% | -201.4% | 100,259.7% | – | – | – | – | – | – | – | – | – | |
| -206.9% | -736.8% | -1,510.8% | -1,018.4% | -357.7% | -535.7% | -97.4% | -399.4% | -954.6% | -2,167.4% | -3,126.1% | -353.9% | -1,615.8% | -1,149.8% | -971.5% | -3,830.4% | – | -168,040.7% | -1,272.2% | -1,648.1% | -6,751.4% | -13,526.2% | -11,894.9% | -11,519.9% | -2,418.8% | -43,604.8% | -69,541.8% | -76,476.4% | -66,194.4% | -92,861.1% | -67,419.4% | -90,268.1% | -89,173.3% | -110,729.2% | -120,711.1% | -134,313.3% | -49.0% | -91,178.0% | -74,397.9% | -44,760.2% | -544.1% | |
| -199.0% | -727.1% | -1,479.7% | -995.5% | -348.0% | -513.0% | -91.6% | -385.0% | -920.4% | -2,103.8% | -3,044.1% | -341.9% | -1,576.3% | -908.9% | -946.3% | -3,736.3% | – | -38,309.3% | -1,273.7% | -1,645.8% | -6,737.0% | -13,509.8% | -11,876.4% | -11,437.5% | -2,399.9% | -43,353.3% | -69,266.3% | -76,062.5% | -65,173.6% | -91,380.6% | -66,402.8% | -89,241.7% | -87,854.7% | -109,366.7% | -119,734.7% | -133,477.3% | -48.1% | -86,081.1% | -71,856.7% | -41,794.0% | -516.8% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.